With the holiday period a distant memory by now, Pharmafocus is back with its January/febraury edition. It’s hard to imagine a more explosive start to the year, as the dust that had settled on a year characterised by stagnation in the mergers & acquisitions department is swiftly blown away with two major deals in one day: Sanofi shells out $11.6 billion for Bioverativ, and Celgene splashes $9 billion to acquire the rest of Juno Therapeutics.
Read Pharmafocus January/February 2018 edition online now!
